Drugs

Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures

LAVAL, QUEBEC: ...

Circassia Announces Duaklir(R) Successfully Met Primary Endpoints in AMPLIFY Phase III Study in Chronic Obstructive Pulmonary Disease

OXFORD, UNITED KINGDOM: ...

Organigram Launches Company''s First Pure CBD Cannabis Oil

MONCTON, NEW BRUNSWICK: "Shubie" developed in response to physician feedback to help those suffering from chronic conditions, including pain ...

ICC International Cannabis Corporation Files Financial Results for the Second Quarter Ended June 30, 2017

VANCOUVER, BRITISH COLUMBIA: ...

Maricann Group Inc. Announces Private Placement of $35 Million of Convertible Debenture Units

TORONTO, ONTARIO: ...

Maricann Group Inc. Enters Into Letter of Intent

TORONTO, ONTARIO: ...

Opthea Presents Additional Positive Data from OPT-302 Phase 1/2a Wet AMD Trial at ASRS Meeting

MELBOURNE, AUSTRALIA: ...

Acasti Pharma Reports First Quarter FY 2018 Financial Results

LAVAL, QUEBEC: ...

Knight Reports Second Quarter 2017 Results

MONTREAL, QUEBEC: ...

Maricann Group Inc. Transitions Financial Management Team

TORONTO, ONTARIO: ...